RICHARD A. YOUNG

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

ENZON PHARMACEUTICALS, INC.

Filing Date Source Excerpt
2010-06-10 Richard A. Young, Ph.D. has served as a director of the Company since April 2010. Dr. Young is a member of the Whitehead Institute and a Professor of Biology at the Massachusetts Institute of Technology.
2011-04-08 Richard A. Young, Ph.D. has served as a director of the Company since April 2010. Dr. Young is a member of the Whitehead Institute and a Professor of Biology at the Massachusetts Institute of Technology...Dr. Young brings to the Board valuable knowledge in disease mechanisms...The Board has nominated and recommends that the stockholders elect Richard A. Young...Director...Age 57...Total Director Compensation 260,543.
2012-04-06 Richard A. Young has served as a director of the Company since April 2010...Dr. Young is a member of the Whitehead Institute and a Professor of Biology at MIT...DIRECTOR COMPENSATION FOR FISCAL YEAR ENDED DECEMBER 31, 2011: Richard A. Young Fees Earned or Paid in Cash ($) 86,319, Stock Awards ($) 75,001, Option Awards ($) 75,003, Total ($) 236,324.

Data sourced from SEC filings. Last updated: 2025-08-30